— Know what they know.
Not Investment Advice
Also trades as: ABL.DE (XETRA) · $vol 0M · ABT.SW (SIX) · $vol 0M

ABT NYSE

Abbott Laboratories
1W: +3.4% 1M: -4.3% 3M: -21.8% YTD: -29.0% 1Y: -34.5% 3Y: -15.8% 5Y: -19.4%
$87.41
-0.36 (-0.41%)
 
Weekly Expected Move ±3.6%
$78 $81 $84 $88 $91
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 52 · $152.3B mcap · 1.73B float · 0.709% daily turnover · Short 29% of daily vol

📊 Key Metrics

TTM
$45B
Revenue
+6.6% YoY
$6B
Net Income
-53.5% YoY
$7B
Free Cash Flow
+10.8% YoY
56.3%
Gross Margin
16.5%
Op. Margin
9.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE12.6%
ROA7.5%
ROIC10.9%

Valuation

P/E24.3
P/B2.9
EV/EBITDA17.1

Leverage

Debt/Equity0.29
Current Ratio1.58
Interest Cov.32.1x

Quality Scores

Piotroski F7/9
Altman Z4.94
Beneish M-2.55

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms